ClariVest Asset Management LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 46.8% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 37,123 shares of the medical instruments supplier’s stock after acquiring an additional 11,837 shares during the quarter. ClariVest […]
Schwartz Investment Counsel Inc. trimmed its position in Haemonetics Co. (NYSE:HAE – Free Report) by 13.6% in the first quarter, Holdings Channel reports. The firm owned 159,000 shares of the medical instruments supplier’s stock after selling 25,000 shares during the quarter. Schwartz Investment Counsel Inc.’s holdings in Haemonetics were worth $13,157,000 as of its most […]
Haemonetics (NYSE:HAE – Get Free Report) announced its quarterly earnings data on Tuesday. The medical instruments supplier reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.32, Briefing.com reports. Haemonetics had a return on equity of 20.13% and a net margin of 9.87%. The business had revenue of […]
Haemonetics (NYSE:HAE – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $3.60-3.90 mln for the period, compared to the consensus earnings per share estimate of $3.59. The company issued revenue guidance of +6-9% yr/yr to ~$1.24-1.27 billion, compared to the consensus […]
Haemonetics (NYSE:HAE – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.60-$3.90 for the period, compared to the consensus estimate of $3.59. The company issued revenue guidance of $1.24 billion-$1.27 billion, compared to the consensus revenue estimate of $1.24 billion. Haemonetics also updated […]